The Albert B. Sabin Vaccine Institute donations received

This is an online portal with information on donations that were announced publicly (or have been shared with permission) that were of interest to Vipul Naik. The git repository with the code for this portal, as well as all the underlying data, is available on GitHub. All payment amounts are in current United States dollars (USD). The repository of donations is being seeded with an initial collation by Issa Rice as well as continued contributions from him (see his commits and the contract work page listing all financially compensated contributions to the site) but all responsibility for errors and inaccuracies belongs to Vipul Naik. Current data is preliminary and has not been completely vetted and normalized; if sharing a link to this site or any page on this site, please include the caveat that the data is preliminary (if you want to share without including caveats, please check with Vipul Naik). We expect to have completed the first round of development by the end of December 2019. See the about page for more details. Also of interest: pageview data on analytics.vipulnaik.com, tutorial in README, request for feedback to EA Forum.

Table of contents

Basic donee information

We do not have any donee information for the donee The Albert B. Sabin Vaccine Institute in our system.

Donee donation statistics

Cause areaCountMedianMeanMinimum10th percentile 20th percentile 30th percentile 40th percentile 50th percentile 60th percentile 70th percentile 80th percentile 90th percentile Maximum
Overall 32 640,485 3,371,160 -3,415,375 -234,948 25,000 50,000 343,791 640,485 1,228,528 3,734,822 4,945,688 10,961,737 34,000,000
Global health 32 640,485 3,371,160 -3,415,375 -234,948 25,000 50,000 343,791 640,485 1,228,528 3,734,822 4,945,688 10,961,737 34,000,000

Donation amounts by donor and year for donee The Albert B. Sabin Vaccine Institute

Donor Total 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006
Bill and Melinda Gates Foundation (filter this donee) 107,877,129.50 1,992,624.00 2,534,845.00 -2,166,847.00 20,000.00 14,545,169.00 8,534,697.00 6,071,478.00 12,085,497.00 3,287,729.50 50,000.00 37,878,155.00 9,252,195.00 13,791,587.00
Total 107,877,129.50 1,992,624.00 2,534,845.00 -2,166,847.00 20,000.00 14,545,169.00 8,534,697.00 6,071,478.00 12,085,497.00 3,287,729.50 50,000.00 37,878,155.00 9,252,195.00 13,791,587.00

Full list of donations in reverse chronological order (32 donations)

DonorAmount (current USD)Amount rank (out of 32)Donation dateCause areaURLInfluencerNotes
Bill and Melinda Gates Foundation1,992,624.00122018-10-12Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to increase knowledge of the burden of enteric fever through the creation of a surveillance network in Asia, where the disease is highly endemic; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation40,000.00252017-11-14Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to support the 2018 Sabin Gold Medal Award which recognizes individuals who have helped to reduce needless human suffering from vaccine-preventable and neglected tropical diseases; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation550,000.00182017-11-01Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to fund a nine-month scoping phase for the relaunch of the International Association for Immunization Managers (IAIM) Network in order to support professional development of immunization managers globally; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation1,194,844.00142017-10-20Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to support the continuation of Sabin’s Coalition Against Typhoid’s hosting of an international meeting series on Typhoid and Other Invasive Salmonelloses, which is an important venue for global typhoid experts to share data and drive the global typhoid co; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation750,001.00152017-06-09Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to provide support for the organization and planning of the International Rotavirus Symposium and to ensure participation of key opinion leaders as well as representatives from Lower Middle Income Countries (LMICs) in the International Rotavirus Symposium; Aid type: Other technical assistance. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation1,228,528.00132016-08-23Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to increase knowledge of the burden of enteric fever through the creation of a surveillance network in Asia, where the disease is highly endemic; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation-640,485.00302016-07-15Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to carry out a planning phase to facilitate coordination of clinical studies of a typhoid conjugate vaccine (TCV), with the ultimate goal of successful World Health Organization (WHO) prequalification of the vaccine for public sector use; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation640,485.00172016-07-15Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to serve as an effective secretariat for the Coalition against Typhoid. Coalition Against Typhoid. Investment start date: 9/3/2010 to end date: 12/31/2018. Grantee name: The Albert B. Sabin Vaccine Institute, Inc.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation20,000.00272016-03-29Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to support for the 2016 Sabin Gold Medal Award which recognizes individuals who have helped to reduce needless human suffering from vaccine-preventable and neglected tropical diseases; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation-3,415,375.00322016-01-14Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to support advocacy efforts that ensure needed momentum in support of the London Declaration, eliminating or significantly reducing the threat that select neglected tropical diseases (NTDs) pose worldwide; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation20,000.00272015-03-18Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to support for the 2015 Sabin Gold Medal Award which recognizes individuals who have helped to reduce needless human suffering from vaccine-preventable and neglected tropical diseases; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation-2,139,362.00312014-12-23Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to support advocacy efforts that ensure needed momentum in support of the London Declaration, eliminating or significantly reducing the threat that select neglected tropical diseases (NTDs) pose worldwide; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation673,946.00162014-11-18Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to carry out a planning phase to facilitate coordination of clinical studies of a typhoid conjugate vaccine (TCV), with the ultimate goal of successful World Health Organization (WHO) prequalification of the vaccine for public sector use; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation4,998,848.0062014-11-12Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to increase knowledge of the burden of enteric fever through the creation of a surveillance network in Asia, where the disease is highly endemic; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation10,961,737.0042014-09-23Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to support advocacy efforts that ensure needed momentum in support of the London Declaration, eliminating or significantly reducing the threat that select neglected tropical diseases (NTDs) pose worldwide; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation50,000.00232014-04-14Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to support the Sabin Vaccine Institute 20th Anniversary Scientific Symposium to convene experts from around the world to examine key lessons from recent efforts to address pressing global health challenges and share insights on emerging immunization trend; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation3,734,822.00102013-10-24Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to serve as an effective secretariat for the Coalition against Typhoid. Coalition Against Typhoid. Investment start date: 9/3/2010 to end date: 12/31/2018. Grantee name: The Albert B. Sabin Vaccine Institute, Inc.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation4,799,875.0082013-08-12Global health/Health policy and administrative managementhttps://iatiregistry.org/publisher/bmgf-- to create sustainable immunization systems in Gavi countries. Sustainable Immunization Financing. Investment start date: 10/15/2007 to end date: 10/15/2016. Grantee name: The Albert B. Sabin Vaccine Institute, Inc.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation317,400.00212012-09-25Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to convene a series of conferences to establish global written standards of Typhoid Vi Capsular Polysaccharide Conjugate Vaccine; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation439,599.00192012-07-05Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to fund scientists from developing countries to attend the 10th, 11th & 12th International Rotavirus Symposiums; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation4,945,688.0072012-06-08Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to create a forum and a platform for immunization program managers to share experiences, increase learning and contribute to global dialogue; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation343,791.00202012-05-19Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to convene researchers in an effort to improve all current efforts, and address existing gaps, in typhoid transmission and disease burden modeling; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation25,000.00262012-03-16Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- for general operating support. Albert B. Sabin Vaccine Institute Gold Medal Award Ceremony. Investment start date: 3/16/2012 to end date: 5/10/2012. Grantee name: The Albert B. Sabin Vaccine Institute, Inc.; Aid type: Core support to NGOs, other private bodies, PPPs and research institutes. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation12,085,497.0032011-04-18Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to provide proof-of-principle that vaccination with two hookworm antigens will reduce infection caused by Necator americanus; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation-234,948.00292010-10-21Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to promote advocacy and resource mobilization for the seven most prevalent NTDs: ascariasis, hookworm infection, trichuriasis, lymphatic filariasis (LF), onchocerciasis, schistosomiasis, and trachoma; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation3,322,780.00112010-09-03Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to serve as an effective secretariat for the Coalition against Typhoid. Coalition Against Typhoid. Investment start date: 9/3/2010 to end date: 12/31/2018. Grantee name: The Albert B. Sabin Vaccine Institute, Inc.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation199,897.50222010-03-30Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to commemorate the 30th anniversary of the declaration that smallpox was eradicated and bring together persons involved to determine lessons that might be applied to future global collaborative efforts; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation50,000.00232009-09-09Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to support the establishment of a regulatory repository or "orphanage" of drugs that are intended for the treatment of neglected tropical diseases; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation34,000,000.0012008-11-21Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to effectively and efficiently mobilize new investments in tropical disease control by scaling up programs; harmonizing disparate efforts to reduce, control or eliminate these diseases; and monitor and evaluate effectiveness; Aid type: Project-type interventions. Affected regions: Africa|North & Central America|South America|Middle East|Developing countries, unspecified|Asia.
Bill and Melinda Gates Foundation3,878,155.0092008-04-04Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to promote advocacy and resource mobilization for the seven most prevalent NTDs: ascariasis, hookworm infection, trichuriasis, lymphatic filariasis (LF), onchocerciasis, schistosomiasis, and trachoma; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation9,252,195.0052007-11-09Global health/Health policy and administrative managementhttps://iatiregistry.org/publisher/bmgf-- to create sustainable immunization systems in Gavi countries. Sustainable Immunization Financing. Investment start date: 10/15/2007 to end date: 10/15/2016. Grantee name: The Albert B. Sabin Vaccine Institute, Inc.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation13,791,587.0022006-08-01Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to produce an effective, manufacturable, affordable and sustainable Human Hookworm Vaccine (HHV); Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.